[Heparanase cloned at last: a new target for antimetastatic drugs]

[miRNAs and cancer].

Bulletin du cancer·2010

[Dietary fibre intake and colon cancer].

Bulletin du cancer·1999

[The role of APC in colonic cancerogenesis: zeroing in on Myc].

Bulletin du cancer·1999

[Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].

Bulletin du cancer·1998

[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].

Bulletin du cancer·2026

[Breaking bad news training in oncology: A French national survey on current practices and unmet needs among oncology residents].

Bulletin du cancer·2026

Hyperpersonalization of cancer care: From tumor location to molecular profile - Key insights and the role of Hospital Oncology Pharmacists. A French Society for Oncology Pharmacy paper.

Bulletin du cancer·2026

[In vivo CAR-T cells: When the patient becomes their own factory].

Bulletin du cancer·2026

Type A acute aortic dissection associated with 5-fluorouracil: A rare but serious vascular toxicity.

Bulletin du cancer·2026

[Implementing a national multidisciplinary meeting board in nephro-oncology: Reports of the first two years of experience].

Bulletin du cancer·2026

Novel missense variants in the RHAG gene that result in Rhmod phenotype.

Transfusion·2026

Design considerations for in silico drug discovery platform that can accelerate targeted drug repurposing: a focus on rare, neglected, and emerging diseases.

Expert opinion on drug discovery·2026

A 6His-2Flag dual-tag strategy enables high-yield production of antimicrobial peptide N6 in Pichia pastoris to combat multidrug-resistant Klebsiella pneumonia.

Synthetic and systems biotechnology·2026

Upstream process optimization and its critical role in chimpanzee adenoviral vector clinical drug development: lessons learned from VRON-0200 manufacturing.

Frontiers in bioengineering and biotechnology·2026

Donor-derived viral infections: the usual suspects and the new kids on the block.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Dual-Biofluid Metabolomics Combined With Machine Learning Enables Noninvasive Diagnosis of Drug Resistance in Benign Prostatic Hyperplasia.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Videos

[Heparanase cloned at last: a new target for antimetastatic drugs]

Related Concept Videos

[miRNAs and cancer].

[Dietary fibre intake and colon cancer].

[The role of APC in colonic cancerogenesis: zeroing in on Myc].

[Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].

[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].

[Breaking bad news training in oncology: A French national survey on current practices and unmet needs among oncology residents].

Hyperpersonalization of cancer care: From tumor location to molecular profile - Key insights and the role of Hospital Oncology Pharmacists. A French Society for Oncology Pharmacy paper.

[In vivo CAR-T cells: When the patient becomes their own factory].

Type A acute aortic dissection associated with 5-fluorouracil: A rare but serious vascular toxicity.

[Implementing a national multidisciplinary meeting board in nephro-oncology: Reports of the first two years of experience].

Novel missense variants in the RHAG gene that result in Rhmod phenotype.

Design considerations for in silico drug discovery platform that can accelerate targeted drug repurposing: a focus on rare, neglected, and emerging diseases.

A 6His-2Flag dual-tag strategy enables high-yield production of antimicrobial peptide N6 in Pichia pastoris to combat multidrug-resistant Klebsiella pneumonia.

Upstream process optimization and its critical role in chimpanzee adenoviral vector clinical drug development: lessons learned from VRON-0200 manufacturing.

Donor-derived viral infections: the usual suspects and the new kids on the block.

Dual-Biofluid Metabolomics Combined With Machine Learning Enables Noninvasive Diagnosis of Drug Resistance in Benign Prostatic Hyperplasia.

Related Experiment Videos

[Heparanase cloned at last: a new target for antimetastatic drugs]

Related Concept Videos

Related Articles